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SUMMARY 
Persistent and latent Japanese ncephalitis virus (JEV) infection was studied in 
pregnant and non-pregnant mice. Following intraperitoneal inoculation into pregnant 
mice JEV persisted for 16 weeks in contrast to 4 weeks in non-pregnant mice. This was 
followed by a higher frequency of latent infection in pregnant mice. The virus could be 
reactivated during pregnancy or by cyclophosphamide tr atment, the latter being more 
effective. 
Following widespread epidemics, Japanese ncephalitis virus (JEV) has become ndemic in 
different parts of India, with a sporadic occurrence of cases throughout the year (Indian Council 
of Medical Research, 1980). Despite extensive studies on non-human amplifiers and reservoirs, 
the mechanism of overwintering of JEV is still not clear. JEV usually causes acute illness but at 
times it may run a protracted course with acute exacerbations, In such cases the brain tissue 
shows chronic as well as acute lesions (Shiraki, 1970). It is not known if these are due to re- 
infection, or to reactivation of a persistent virus. Evidence of persistent infection with JEV has 
been described in mammalian and mosquito cell lines (Schmaljohn & Blair, 1979; Rehacek, 
1968) and from studies in bats (Ito & Saito, 1952). Defective interfering particles have been 
found to be responsible for establishment and maintenance of JEV persistent infection in vitro 
(Schmaljohn & Blair, 1979). 
A number of viruses can establish persistent infection in the host (Stroop & Baringer, 1982) 
but the mechanism of virus persistence is complex. The main feature in such an infection is 
evasion of the host immune response resulting in a failure to eliminate the virus (Mahy, 1985). 
We have described a JEV-mouse model to study the transplacental transmission of the virus 
(Mathur et al., 1981), a phenomenon observed in human cases during the 1978 epidemic in India 
(Chaturvedi et al., 1980). Pregnant mice initially infected uring pregnancy could transmit JEV 
to foetuses 6 months later during subsequent pregnancies (Mathur et al., 1982). These 
observations are of great significance if true for humans also. Therefore, in this report an effort 
was made to study the establishment of persistence, latency and reactivation of JEV in pregnant 
and non-pregnant mice. 
JEV strain 78668A was used as an adult Swiss albino mouse brain suspension. Evidence has 
been presented earlier showing the pr sence of JEV in spleen, thymus and kidney up to 11 days 
after infection in mice inoculated uring pregnancy (Mathur et al., 1981). To examine further 
the period of virus production from different organs, 100 LDs0 of JEV was given 
intraperitoneally (i.p.) to pregnant mice on day 8 of the pregnancy. Non-pregnant female mice 
of similar age were inoculated similarly. From each group six or seven mice were sacrificed at 
weekly intervals. Different organs, i.e. spleen, liver, kidney, thymus, ovary, brown fat and 
blood, were collected aseptically. Organ homogenates (10 %, w/v) were assayed for the presence 
of JEV by intracerebral (i.c.) inoculation into suckling mice. Virus identification was done by 
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Fig. 1. Japanese ncephalitis virus titres in the thymus of pregnant (©) and non-pregnant (0)  mice 
inoculated i.p. with 10 2 LDso virus. Each point represents he mean infectivity titre from six or seven 
mice individually assayed. 
Table 1. Isolation of  virus from different organs of pregnant and non-pregnant mice given JEV  by i.p. 
route 
Time after Positive isolations/total mice tested 
infection r ~ 
(weeks) Thymus Spleen Brown fat Kidney Ovary 
1 6/6 (5/6)* 6/6 (5/6) 0/6 (0/6) 2/6 (4/6) 0/6 (0/6) 
2 6/6 (3/6) 6/6 (3/6) 2/6 (3/6) 4/6 (3/6) 2/6 (2/6) 
3 6/6 (3/6) 6/6 (3/6) 5/6 (2/6) 4/6 (2/6) 4/6 (1/6) 
4 6/6 (2/7) 6/6 (0/7) 5/6 (2/7) 4/6 (0/7) 4/6 (0/7) 
5 6/6 6/6 4/6 3/6 4/6 
6 6/7 5/7 4/7 3/7 4/7 
7 5/7 5/7 4/7 3/7 3/7 
8 4/7 4/7 4/7 2/7 3/7 
9 4/7 3/7 3/7 2/7 3/7 
10 3/6 4/6 3/6 2/6 3/6 
11 3/6 3/6 3/6 0/6 2/6 
12 3/6 2/6 2/6 0/6 2/6 
13 2/6 2/6 2/6 0/6 1/6 
14 2/6 1/6 2/6 0/6 0/6 
15 2/6 0/6 2/6 0/6 0/6 
16 2/6 0/6 1/6 0/6 0/6 
* Results for non-pregnant mice ar given in parentheses. 
neutralization tests in infant mice using hyperimmune sera (Mathur et al., 1981) supplied by the 
National Institute of Virology, Pune, India. 
The results of virus isolation from different organs of pregnant mice at various times after i.p. 
infection are summarized in Table 1. The virus was isolated from thymus and spleen in all mice 
tested 1 to 5 weeks after infection. Of the 100 mice examined over a period of 16 weeks, JEV was 
consistently recovered from all organs shown i Table 1. The longest periods during which virus 
could be isolated (up to 16 weeks) were observed in thymus and brown fat. Blood and liver 
contained virus in the first week only, and no virus could be isolated from brain tissue on any 
occasion. Virus titres in the thymus reached 104.3 LDso/g of tissue at the second week, which was 
higher than at any other time and in any other organ (Fig. 1). 
The findings summarized in Table 1 show a briefer period of virus shedding after JEV 
infection of non-pregnant mice than of the pregnant mice. In this group also the JEV isolation 
rate was higher in the thymus (13/25) than in any other organ. Maximum infectivity titres in the 
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Table 2. Antibody response after i.p. inoculation of JEV in pregnant and non-pregnant mice 
JEV HAI titre in serum* 
383 
Time Pregnant Non-pregnant 
post-immunization • J" ~ c ~" 
(weeks) Buffer'}" 2-ME:~ Buffer]" 2-ME~ 
Before inoculation < 8 < 8 < 8 < 8 
1 12 + 2.1 <8 11 + 4.3 <8 
2 51 + 3 8 42 + 3.5 8 
3 102 + 21 90 + 7 90 _ 11 90 + 11 
4 102 + 8 102 + 15 102 + 19 102 + 4 
5 102 + 19 102 + 9.1 102 + 15 102 + 15 
27 90 + 3-5 90 + 3-2 90 + 7 90 +__ 12 
* HA1, Haemagglutination inhibiting antibody. The reciprocal dilution of theserum giving inhibition against 8 
HA units of antigen is presented. Each HA1 value represents the mean value with s.D. from five to seven mice. 
I" Serum aliquot treated with buffer. 
:~ Serum aliquot treated with 2-mercaptoethanol. 
thymus were 102'1 to 102.5 LD50/g of tissue at the second week, which was significantly less than 
that in pregnant mice (Fig. 1). No virus was isolated from brain at any time. 
An attempt was made to isolate infectious virus between 17 and 26 weeks after infection from 
mice infected during pregnancy and 5 to 26 weeks post-infection from those infected when not 
pregnant. Every week three to five mice of each group were killed and tests for virus made on 
tissue homogenates (thymus, spleen, kidney, brain, brown fat and ovaries). Infectious virus was 
present in tissues of only one out of 45 (2.2~) mice in the pregnant group and in none of the 46 
non-pregnant animals. From each of the remaining mice an open surgical biopsy of the thymus 
was done at week 26 and the resected tissue was homogenized and assayed for JEV. Mice that 
had JEV in the thymus were excluded from the study and the remainder were defined as latently 
infected. 
For reactivation experiments those latently infected mice were selected which had shown 
evidence of infection after i.p. inoculation of virus either by in utero transmission of virus to 
foetuses or by the presence of JEV-specific haemagglutination-inhibiting (HAI) antibodies. 
After 27 weeks an attempt was made to reactivate the virus by inducing pregnancy (presence of 
vaginal plug after mating with normal male) or by cyclophosphamide (CY) treatment (200 
mg/kg body weight, i.p.; Endoxan-ASTA, Khandelwal Laboratories Pvt., ASTA Werke AG,  
F.R.G.). On alternate days, seven to 11 mice from each group were sacrificed and thymus, 
spleen, liver, brown fat and blood tested for infectious virus. 
After CY inoculation at 27 weeks post-infection, seven of 11 mice infected during pregnancy 
and five of 11 infected when not pregnant showed reactivation of virus. The virus was isolated in 
both groups from blood and thymus as early as on day 3 after CY treatment and later from other 
organs. Reactivation occurred during pregnancy in five of 11 mice originally infected when 
pregnant and in four of 11 mice originally infected when not pregnant. CY is a potent 
immunosuppressive agent and caused reactivation of the virus more frequently than did 
pregnancy. Some of the mice in each of the groups were allowed to give birth. Reactivated virus 
can be transmitted transplacentally, resulting in neonatal deaths as reported earlier (Mathur et 
al., 1982). Virus was isolated from 13 to 17~ of the newborns from these groups. 
Reactivation of virus was also found in mice infected with JEV approximately 1 year earlier 
and found to be latently infected as defined above by thymic biopsy. After CY inoculation at 52 
weeks after infection reactivation occurred in seven of 11 mice infected during pregnancy and 
four of nine infected when not pregnant. The virus was isolated from thymus and blood. This 
shows that virus can remain latent for at least 1 year. 
The findings summarized in Table 2 show the HAI  (estimated by the method of Clarke & 
Casals, 1958) and IgM (estimated before and after 2-mercaptoethanol treatment) antibody titres 
in serum before and after JEV infection. The peak HA l  antibody titres were observed at 3 weeks 
post-infection i both infected groups, while the JEV IgM HAI  antibodies were present for only 
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2 weeks after infection and were absent at 17 weeks in all the sera tested at 27 weeks after 
infection. The HAI antibody titres were maintained at approximately the same level. JEV 
evidently persisted in mice despite the continuous presence of significant levels of serum 
antibody. 
Protection against JEV is provided by T lymphocytes and by IgM antibodies which are 
present until about 2 weeks after infection (Mathur et al., 1983). At later times these responses 
are depressed ue to the appearance of specific suppressor T cells (Mathur et al., 1984). If the 
short-lived protective cell-mediated immunity and IgM antibody responses by themselves are 
not sufficient to terminate infection, the virus persists. Papovaviruses (Walker & Padgett, 1983) 
and herpes implex viruses (Wildy & Gell, 1985) can persist hroughout the life of the host in a 
latent form. 
The virus titres were significantly higher in different organs of pregnant mice than in non- 
pregnant mice. Furthermore, the virus persisted for up to 4 weeks in non-pregnant mice after 
primary infection while in pregnant mice it persisted for 16 weeks. Pregnancy is known to be 
associated with immunosuppression. Therefore, failure of pregnant mice to clear JEV for up to 
16 weeks might be a result of pregnancy-induced immunosuppression. Immunosuppression 
delays coxsackie B4 virus elimination from ICR Swiss mice (Khatib et al., 1983) and may help in 
establishment of persistent infection of lymphocytes and macrophages by lentiviruses (Mires, 
1982). An increase in virus titre due to immunosuppression after CY treatment has been 
reported in coxsackie B3 (Rager-Zisman & Allison, 1973) and dengue 2(Chaturvedi et al., 1977) 
virus infections of mice. 
The simultaneous appearance of virus in thymus and blood before detection in other organs 
may indicate that it is reactivated in the thymus and then disseminated; the above experiments 
show that infectious JEV persists longer in the thymus than in other organs. Thymic cells might 
therefore be useful for the study of latency. 
Attenuated JEV vaccines have been developed to control infection in humans as well as in 
JEV amplifiers. Live attenuated vaccines for bluetongue virus (BTV 10) and Rift Valley fever 
virus have been implicated in causing congenital disorders when administered uring 
pregnancy (Shultz & DeLay, 1955; Coetzer & Barnard, 1977), and similar effects should be 
considered for JEV vaccines. 
The natural route of JEV infection in man is through the bite of a mosquito, which cannot be 
equated with the i.p. route used in our mouse xperiments. However, inapparent infection and 
transplacental transmission ofthe virus seen in human cases (Chaturvedi et al., 1980; Mathur et 
al., 1985) can be reproduced in mice by giving JEV i.p. (Mathur et al., 1981). Findings on the 
persistence, latency and reactivation f JEV in the mouse model suggest that such phenomena 
could occur in human cases. 
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